50 results on '"Casanova, Ciro"'
Search Results
2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
3. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
4. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
5. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study
6. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017
7. Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach
8. The 7 Cardinal Sins of COPD in Spain
9. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
10. [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
11. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
12. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
13. Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study
14. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study
15. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
16. [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome
17. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
18. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
19. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
20. Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers
21. Home noninvasive ventilation in severe COPD: in whom does it work and how?
22. Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
23. Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years
24. Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study
25. Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study
26. A longitudinal and multidesign epidemiological study to analyze the effect of the volcanic eruption of Tajogaite volcano (La Palma, Canary Islands). The ASHES study protocol
27. Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation : a population-based study
28. Analysis of Exposure and Respiratory Health Effects of Volcanic Eruption in the Canary Islands (ASHES). A SEPAR Study
29. Unravelling young COPD and pre-COPD in the general population
30. Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years
31. Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
32. Associations between serum mitokine levels and outcomes in stable COPD
33. [Translated article] ANTES Program: One Year on
34. ANTES: Un año después en la EPOC
35. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome
36. Additional file 1 of Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
37. Chest CT ‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort
38. ANTES: Un año después en la EPOC
39. WITHDRAWN: Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome
40. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
41. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
42. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment
43. The burden of COPD in young individuals: results from EPISCAN II
44. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD
45. Unravelling young COPD and pre-COPD in the general population.
46. Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
47. The ANTES program in COPD: First year.
48. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
49. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome.
50. Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.